Rchr

J-GLOBAL ID：200901016032242687 Update date: Jan. 30, 2024

Kawai Yoshiko

カワイヨシコ | Kawai Yoshiko

Affiliation and department：

Research field (2)： Pharmacology , Pharmaceuticals - health and biochemistry

Research keywords (2)：薬理学 , Pharmacology

Research theme for competitive and other funds (3)：

2014 - 2017 Pathophysiological analysis of epilepsy with focusing on the synaptic release mechanism
1988 - 薬物性腎障害および慢性腎不全発症機序における活性酸素の役割
1988 - Study on role of reactive oxygen species on renal failure

Papers (5)：

Yoshiko Kawai, Tomohiko Satoh, Daisuke Hibi, Yukihiro Ohno, Yuka Kohda, Katsuyuki Miura, Munekazu Gemba. The Effect of Antioxidant on Development of Fibrosis by Cisplatin in Rats. JOURNAL OF PHARMACOLOGICAL SCIENCES. 2009. 111. 4. 433-439
KOHDA Yuka, MATSUNAGA Yoshiko, SHIOTA Ryugo, SATOH Tomohiko, KISHI Yuko, KAWAI Yoshiko, GEMBA Munekazu. INVOLVEMENT OF RAF-1/MEK/ERK1/2 SIGNALING PATHWAY IN ZINC-INDUCED INJURY IN RAT RENAL CORTICAL SLICES. Journal of toxicological sciences. 2006. 31. 3. 207-217
Yuka Kohda, Yoshiko Matsunaga, Katsuya Yonogi, Yoshiko Kawai, Akira Awaya, Munekazu Gemba. Protective effect of serum thymic factor, FTS, on cephaloridine-induced nephrotoxicity in rats. Biological and Pharmaceutical Bulletin. 2005. 28. 11. 2087-2091
Yoshiko Kawai, Yuka Kohda, Takaaki Kodawara, Munekazu Gemba. Protective effect of a protein kinase inhibitor on cellular injury induced by cephaloridine in the porcine kidney cell line LLC-PK1. Journal of Toxicological Sciences. 2005. 30. 3. 157-163
Hiroko Takano, Takafumi Imada, Yohei Hayashi, Yuko Suzuki, Yuka Kohda, Yoshiko Kawai, Munekazu Gemba. Role of reactive oxygen species in tubulointerstitial fibrosis in rats. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN. 2005. 125. 97-99

MISC (16)：

ｍore...

Professional career (1)：

抗悪性腫瘍薬シスプラチンによる腎毒性発現機序に関する研究 (大阪薬科大学)

Association Membership(s) (5)：

日本腎臓学会 , 日本過酸化脂質・フリーラジカル学会 , 日本毒科学会 , 日本薬学会 , 日本薬理学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM